ABSTRACT
INTRODUCTION
Photodynamic therapy (PDT) is a treatment modality using light to activate a photosensitizer, which transfers energy to ground-state tissue oxygen and generates singlet-state oxygen ( 1 O 2 ). Singlet oxygen is considered as the main cytotoxic species causing therapeutic effects via reacting with the surrounding biological molecules. These reactions usually take place so rapidly that direct in-vivo monitoring on 1 O 2 becomes very difficult. The in-vivo life time of singlet oxygen is estimated to be in the range of 30 -180 ns. 1 The surrogate way to derive information about temporal and spatial distribution of singlet oxygen is to use mathematical models.
2,3,4,5,6
Wang et al 5 introduced a macroscopic model to determine a PDT dosimetry parameter -"reacted singlet oxygen threshold concentration"([
In addition, the model has four other PDT parameters: ξ, σ, β and g that are defined as initial oxygen consumption rate, ratio of photobleaching to reaction between 1 O 2 and cellular targets, ratio of triplet state (T) phosphorescence to reaction between T and oxygen ( 3 O 2 ), and oxygen perfusion supply rate to tissue, respectively. In Wang's previous work, 5 all five parameters were examined for photosensitizer Photofrin using radiation-induced fibrosarcoma (RIF) tumors in an in-vivo C3H mouse model. Following this, some preliminary studies have been performed on a different photosensitizer, 2-(1-Hydroxyethyl)-2-Devinylpyropheophorbide-a (HPPH), using the same tumor model. RIF tumor model by investigating more treatment conditions. The second goal is to compare the parameters derived from the two in-vivo tumor models. This manuscript will show the comparison results.
THEORY AND METHOD

The macroscopic model
This section briefly describes our previously introduced macroscopic PDT model and the definition of the five parameters to be derived by fitting the in vivo experimental results. The more detailed description of the model and the fitting routine can be found elsewhere.
5
The coupled time-dependent differential equations, as shown in equations (1) (3) over time.
In these studies, light fluence rate distribution within tumor tissue is calculated for a linear source with source strength S L using diffusion theory as shown in equation (4) . The definitions of the parameters are given in 5 Hence, the value of 11.9 µM for Photofrin has been adapted in the model as no value for HPPH is reported in the literature. 
Symbol Definition Units
ξ S ∆ k5 k5+k3 σc hν k7[A]/k6 k7[A]/k6+1 (cm 2 mW −1 s −1 ) σ k 1 /k 7 [A] µM −1 δ Low drug concentration correction µM β k 4 /k 2 µM [A] Molecular substrate M k 1 Bimolecular rate constant for reaction of 1 O 2 with S 0 M −1 s −1 k 2 Bimolecular rate constant for reaction of 3 O 2 with T 1 M −1 s −1 k 3 S 1 → S 0 s −1 k 4 T 1 → S 0 s −1 k 5 S 1 → T 1 s −1 k 6 1 O 2 → 3 O 2 s −1 k 7 Bimolecular
In vivo mouse experiments for HPPH-PDT
Two cohorts of mouse experiments were performed for these studies. One was performed with C3H female mice (about 9 weeks old) with RIF tumors grown intradermally on their right shoulders. This cohort was designed to expand treatment conditions based on our previous work in order to refine the parameters. The other group was conducted using nude female mice (about 9 weeks old) with H460 tumors to investigate the dependency of the parameters on different tumor types.
For both groups, mice were given HPPH (0.25 mg/kg) via tail vein injection when the radius of tumor was about 4 mm, and treated with two-catheter interstitial PDT using a 665 nm linear light source (1 cm) after 24 hrs of incubation time. The treatment light source was placed in one of two parallel catheters inserted along the central axis of the tumor. Prior to PDT, a point source coupled to a 665 nm laser was placed in the central catheter, and an isotropic point detector was inserted in the other parallel catheter to measure light fluence rate profiles. The measured light fluence rates were then fitted using diffusion approximation to extract the spatial distribution of optical properties of tumor. The in vivo photosensitizer concentration was determined by measuring the in vivo HPPH fluorescence spectra excited by a 405 nm diode laser. The spectra were collected along the non-central catheter, and then analyzed using singular value decomposition (SVD) method. After the correction for the attenuation of the fluorescence photons due to absorption of tumor using measured optical properties of tumor, the spectra were compared with that measured in phantom of known HPPH concentration to extract the in vivo HPPH concentration. The obtained other three PDT parameters (ξ, σ and g) are shown in table 4, and they are mostly consistent except for the g for H460 is little higher. 
RESULTS AND DISCUSSIONS
CONCLUSION
These studies use our macroscopic model to fit in vivo HPPH-mediate PDT experimental results for the RIF and H460 tumor models so that photochemical PDT parameters can be obtained. These parameters between two tumor models are similar. Singlet oxygen threshold dose are 0.41 and 0.37 mM for RIF and H460 respectively.
